Strattera (Atomoxetine)
Strattera is a non-stimulant medication used to improve attention & impulse control in individuals with ADHD, offering benefits without the abuse potential associated with stimulant medications.
Evidence last reviewed: 05 Apr 2026
Not a routine supplement — not recommended for self-directed use.
Information here is educational only, not a recommendation to use. See our Safety page.
Evidence is from research or clinical settings — does not imply safety outside supervised contexts.
Atomoxetine has moderate to high-quality evidence supporting its efficacy in reducing ADHD symptoms and improving quality of life. While it shows promise, the evidence is primarily focused on specific populations, and further research may be needed to explore long-term effects.
ADHD symptom severityChildren and adolescents with ADHD · Systematic reviewHigh
Atomoxetine was found to be superior to placebo in reducing ADHD core symptoms.
Quality of lifePeople with ADHD · Meta-analysisModerate
Atomoxetine improved quality of life with moderate effect size compared to placebo.
Quality of lifePeople with ADHD · Systematic reviewModerate
Atomoxetine was associated with improvements in quality of life compared to placebo.
ADHD symptom severityAdults with ADHD · Systematic reviewModerate
Nonstimulant medications, including atomoxetine, were efficacious in reducing ADHD core symptom severity.